The soluble guanylate cyclase stimulator IW‐1973 prevents inflammation and fibrosis in experimental non‐alcoholic steatohepatitis

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|175|6|953-967

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.175, Iss.6, 2018-03, pp. : 953-967

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beneficial effects of mineralocorticoid receptor blockade in experimental non‐alcoholic steatohepatitis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 9, 2015-09 ,pp. : 2129-2138

John Wiley & Sons Inc

Access to resources Recommend Favorite

The pan‐caspase inhibitor Emricasan (IDN‐6556) decreases liver injury and fibrosis in a murine model of non‐alcoholic steatohepatitis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 953-966

John Wiley & Sons Inc

Access to resources Recommend Favorite

High‐fat and high‐cholesterol diet rapidly induces non‐alcoholic steatohepatitis with advanced fibrosis in Sprague–Dawley rats

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 4, 2015-04 ,pp. : 458-469

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of serum toll‐like receptors 2 and 4 in non‐alcoholic steatohepatitis and liver fibrosis

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 7, 2015-07 ,pp. : 1190-1196

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rifaximin in non‐alcoholic steatohepatitis: An open‐label pilot study

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 1, 2018-01 ,pp. : 69-77

John Wiley & Sons Inc

Access to resources Recommend Favorite